SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
15-Aug-22 5:34 PM View: | Athenex, Inc. (ATNX) | 03-Aug-22 | Payment of Exercise | 3,663 | $0.58 | $2,126.74 | (1%) 249.61K to 245.94K | |
15-Aug-22 5:34 PM View: | Athenex, Inc. (ATNX) | 03-Aug-22 | Option Exercise | 12,500 | -- | -- | 5% 237.11K to 249.61K | |
10-Sep-20 4:44 PM View: | Athenex, Inc. (ATNX) | 10-Sep-20 | Option Exercise | 18,180 | $11.00 | $199,980.00 | 8% 218.93K to 237.11K | 8% |
12-Mar-20 4:15 PM View: | Athenex, Inc. (ATNX) | 12-Mar-20 | Market Purchase | 10,000 | $8.14 | $81,430.00 | 5% 208.93K to 218.93K | 45% |
17-Apr-19 4:10 PM View: | Athenex, Inc. (ATNX) | 16-Apr-19 | Grant | 10,717 | -- | -- | 5% 198.21K to 208.93K | |
14-Nov-18 5:25 PM View: | Athenex, Inc. (ATNX) | 14-Nov-18 | Market Purchase | 9,500 | $10.49 | $99,655.00 | 5% 188.71K to 198.21K | 13% |
26-Mar-18 4:32 PM View: | Athenex, Inc. (ATNX) | 26-Mar-18 | Market Purchase | 5,000 | $14.69 | $73,450.00 | 3% 183.71K to 188.71K | (20%) |
01-Apr-15 5:30 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 27-Feb-15 | Gift | 48,850 | -- | -- | (7%) 734.86K to 686.01K | |
27-Feb-15 3:59 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 25-Feb-15 | Grant | 9,945 | -- | -- | 1% 676.07K to 686.01K | |
24-Feb-15 6:10 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 22-Feb-15 | Payment of Exercise | 918 | $28.50 | $26,163.00 | (< 1%) 676.99K to 676.07K | 45% |
24-Feb-15 6:10 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 21-Feb-15 | Payment of Exercise | 1,227 | $28.50 | $34,969.50 | (< 1%) 678.21K to 676.99K | 45% |
20-Feb-15 4:39 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 18-Feb-15 | Payment of Exercise | 1,053 | $27.22 | $28,662.70 | (< 1%) 679.27K to 678.21K | 42% |
24-Feb-14 9:43 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 22-Feb-14 | Payment of Exercise | 955 | $21.75 | $20,771.20 | (< 1%) 680.22K to 679.27K | 28% |
24-Feb-14 9:43 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 21-Feb-14 | Payment of Exercise | 1,279 | $21.84 | $27,933.40 | (< 1%) 681.5K to 680.22K | 28% |
19-Feb-14 9:14 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 18-Feb-14 | Grant | 13,393 | -- | -- | 2% 668.11K to 681.5K | |
17-Sep-13 5:37 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 16-Sep-13 | Sale | 85,813 | $20.03 | $1,718,680.00 | (11%) 754.85K to 669.04K | |
02-Jan-14 3:33 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 22-Feb-13 | Payment of Exercise | 928 | $16.85 | $15,636.80 | (< 1%) 669.04K to 668.11K | 7% |
25-Feb-13 8:06 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 21-Feb-13 | Grant | 15,805 | -- | -- | 2% 739.04K to 754.85K | |
24-Feb-12 7:52 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 22-Feb-12 | Grant | 11,800 | -- | -- | 2% 692.16K to 703.96K | |
19-Apr-12 6:37 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 23-Jul-11 | Option Exercise | 15,948 | $4.31 | $68,735.90 | 2% 723.1K to 739.04K | |
19-Apr-12 6:37 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 01-Jun-11 | Option Exercise | 19,138 | $4.23 | $80,953.70 | 3% 703.96K to 723.1K |